Literature DB >> 21862344

Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children.

Yoshinori Ito1, Yuka Torii, Rieko Ohta, Masaki Imai, Shinya Hara, Yoshihiko Kawano, Tadashi Matsubayashi, Ayano Inui, Tetsushi Yoshikawa, Naoko Nishimura, Takao Ozaki, Tsuneo Morishima, Hiroshi Kimura.   

Abstract

BACKGROUND: The 2009 A(H1N1) influenza virus has caused a large outbreak, and resulted in major complications of severe pneumonia and acute encephalopathy in the pediatric population in Japan.
METHODS: This study examined six patients with acute encephalopathy, 34 patients with severe pneumonia, five patients with both pneumonia and encephalopathy, and 46 patients without severe complications. The concentrations of 27 cytokines were examined in the cerebrospinal fluid of patients with encephalopathy, and the levels of these cytokines, Cytochrome c, high-mobility group box 1 (HMGB1) were measured in the serum of all patients.
RESULTS: Patients with severe pneumonia had higher serum concentrations of 16 cytokines, including Th1 cytokines, Th2 cytokines, chemokines, and growth factors, than patients with uncomplicated influenza. The distribution of 27 cytokines in the CSF did not parallel the serum levels in 11 patients with acute encephalopathy. HMGB1 concentrations in the serum were significantly higher in pneumonia patients with or without encephalopathy than in uncomplicated influenza patients, and were significantly associated with the upregulation of 10 cytokines.
CONCLUSIONS: Elevated levels of Th2 cytokines appear to be unique to influenza caused by 2009 H1N1 influenza virus and HMGB1 could play an important role in the pathogenesis of severe pneumonia. There appear to be different pathologic processes for encephalopathy and pneumonia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862344     DOI: 10.1016/j.cyto.2011.07.016

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  17 in total

1.  HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication.

Authors:  Dorothée Moisy; Sergiy V Avilov; Yves Jacob; Brid M Laoide; Xingyi Ge; Florence Baudin; Nadia Naffakh; Jean-Luc Jestin
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

2.  Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis.

Authors:  Mitsuru Tsuge; Takashi Oka; Nobuko Yamashita; Yukie Saito; Yosuke Fujii; Yoshiharu Nagaoka; Masato Yashiro; Hirokazu Tsukahara; Tsuneo Morishima
Journal:  J Neurovirol       Date:  2014-01-24       Impact factor: 2.643

3.  Elevated levels of high-mobility group box-1 (HMGB1) in patients with severe or uncomplicated Plasmodium falciparum malaria.

Authors:  Davide Angeletti; Mpungu Steven Kiwuwa; Justus Byarugaba; Fred Kironde; Mats Wahlgren
Journal:  Am J Trop Med Hyg       Date:  2013-02-11       Impact factor: 2.345

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  High mobility group box 1 protein as an auxiliary biomarker for dengue diagnosis.

Authors:  Diego Allonso; Susana Vázquez; Maria G Guzmán; Ronaldo Mohana-Borges
Journal:  Am J Trop Med Hyg       Date:  2012-12-26       Impact factor: 2.345

6.  Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.

Authors:  Nobuyuki Nosaka; Masato Yashiro; Mutsuko Yamada; Yosuke Fujii; Hirokazu Tsukahara; Keyue Liu; Masahiro Nishibori; Akihiro Matsukawa; Tsuneo Morishima
Journal:  Crit Care       Date:  2015-06-11       Impact factor: 9.097

7.  Local and Systemic Immune Responses to Influenza A Virus Infection in Pneumonia and Encephalitis Mouse Models.

Authors:  Yoshiharu Nagaoka; Nobuyuki Nosaka; Mutsuko Yamada; Masato Yashiro; Yosuke Washio; Kenji Baba; Tsuneo Morishima; Hirokazu Tsukahara
Journal:  Dis Markers       Date:  2017-08-24       Impact factor: 3.434

Review 8.  Human Platelets and Influenza Virus: Internalization and Platelet Activation.

Authors:  Josiah Bote; Heather A Corkrey; Milka Koupenova
Journal:  Platelets       Date:  2021-08-08       Impact factor: 3.862

9.  HMGB1 Is a Potential Biomarker for Severe Viral Hemorrhagic Fevers.

Authors:  Katarina Resman Rus; Luka Fajs; Miša Korva; Tatjana Avšič-Županc
Journal:  PLoS Negl Trop Dis       Date:  2016-06-27

10.  Circulating level of high mobility group box‑1 predicts the severity of community‑acquired pneumonia: Regulation of inflammatory responses via the c‑Jun N‑terminal signaling pathway in macrophages.

Authors:  Hsiang-Ling Wang; Shih-Ming Tsao; Chao-Bin Yeh; Ying-Erh Chou; Shun-Fa Yang
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.